Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2013-04-01 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Allied lodges 510(k) with FDA for CardioCel 3 pages 201.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Allied Healthcare Group regarding the lodging of a 510(k) Premarket Notification submission with the FDA for marketing approval of their product CardioCel®. The text focuses on the regulatory milestone of submitting the 510(k) application, describing the product and its potential market impact. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is a regulatory announcement about a specific event (the 510(k) submission) rather than a financial report or earnings release. It is not a report publication announcement since it contains substantive information about the event itself. Therefore, the document fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2013-04-01 English
Shareholder Newsletter - March 2013 4 pages 882.1KB
Fund Information / Factsheet Classification · 90% confidence The document is a detailed shareholder update newsletter from Allied Healthcare Group dated March 2013. It provides progress updates on company activities, product development milestones, financial position, upcoming events, and research progress. It is not a formal financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing or announcement of voting results. It is also not a call transcript, audit report, or capital update. The content is focused on shareholder communication with operational and strategic updates, typical of a shareholder newsletter or investor update. Given the detailed nature and length (over 13,000 characters), it is more than a brief factsheet or presentation. The best fitting category is Fund Information / Factsheet (FS), which includes brief summaries and updates for shareholders and investors, often in newsletter format. Therefore, the classification is FS with high confidence.
2013-03-26 English
Clinical Trial Extension Study Update - No Calcification 3 pages 200.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Allied Healthcare Group providing an update on a clinical trial extension study for their CardioCel implant. It discusses clinical trial results, product development progress, and regulatory approval plans. There are no financial statements, earnings data, or detailed financial analysis. The content is focused on clinical trial progress and product development rather than financial or regulatory filings. It is not a report publication announcement or a certification. The document is a corporate announcement about clinical trial progress and product development status, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like earnings release, annual report, or capital update.
2013-03-05 English
Half Yearly Report 24 pages 128.8KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX release dated 21 February 2013, titled 'Half Yearly Report (Appendix 4D) for the 6 months ended 31 Dec 2012'. It includes detailed financial results, directors' report, financial report, directors' declaration, and audit report for the half-year period ending 31 December 2012. The presence of comprehensive financial data, directors' commentary, and audit information indicates this is a formal interim financial report. The document is about 15,000 characters long, which is consistent with a full interim report rather than a brief announcement. The document explicitly states it is a 'Half Yearly Report' and includes financial statements and analysis for the half-year period. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2013
2013-02-21 English
Response to ASX query 5 pages 362.5KB
Regulatory Filings Classification · 95% confidence The document is a letter exchange between ASX Compliance and Allied Healthcare Group regarding the materiality and disclosure of certain study results. It discusses compliance with ASX listing rules, specifically rule 3.1 about continuous disclosure of material information. The document is a regulatory correspondence clarifying whether the study results are material and whether the company complied with disclosure obligations. It does not contain financial statements, earnings data, or detailed financial analysis. It is not an announcement of financial results, a report, or a presentation. It is a regulatory filing responding to a compliance inquiry from the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and compliance documents that do not fit other categories.
2013-02-18 English
Replacement form - Change in substantial holding 2 pages 132.3KB
Regulatory Filings
2013-02-14 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.